Aeterna Zentaris (NASDAQ:AEZS) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research report sent to investors on Tuesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reduced their price target on shares of Aeterna Zentaris from $28.00 to $15.00 and set a buy rating […]

Leave a Reply

Your email address will not be published.

Previous post AC Immune’s (ACIU) “Buy” Rating Reaffirmed at HC Wainwright
Next post Boyd Group Services (TSE:BYD) Price Target Increased to C$275.00 by Analysts at Desjardins